RITUXIMAB

214104 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB:

# Side effect Count
0 OFF LABEL USE 41722
1 DRUG INEFFECTIVE 34408
2 RHEUMATOID ARTHRITIS 20327
3 PAIN 17935
4 FATIGUE 17483
5 RASH 13683
6 ARTHRALGIA 13466
7 PNEUMONIA 13256
8 INFUSION RELATED REACTION 12870
9 DRUG INTOLERANCE 12675
See all common reactions for RITUXIMAB

RITUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5866 0.8179
1 PEMPHIGUS 9533 0.7617
2 RED BLOOD CELL SEDIMENTATION RATE 211 0.7563
3 SWOLLEN JOINT COUNT INCREASED 2385 0.7472
4 RHEUMATIC FEVER 3300 0.7396
5 VACCINE INTERACTION 228 0.7355
6 RHEUMATOID FACTOR POSITIVE 4241 0.7335
7 SWOLLEN JOINT COUNT 182 0.7280
8 C-REACTIVE PROTEIN 659 0.7109
9 LUPUS VULGARIS 881 0.6992
See all enriched reactions for RITUXIMAB